# Stage 5 review — 2026-05-24

Reviewing the Stage 5 deliverables for Vinamilk (VNM) at `hieptran-mbbank/Corporate-Finance`.

## Artifact checklist

| # | Artifact | Present? | Path |
|---|----------|----------|------|
| 1 | Raw LLM output | Yes | `deliverables/2026-05-24-tran-vinamilk-llm-raw.md` |
| 2 | Manual verification table | Yes | `analysis/validation/2026-05-24-tran-vinamilk-stage5-verification.md` |
| 3 | Final analysis | Yes | `deliverables/2026-05-24-tran-vinamilk-final-analysis.md` |
| 4 | Spec retrospective | Yes | `deliverables/2026-05-24-tran-vinamilk-spec-retrospective.md` |
| 5 | Prompt log | Yes | `deliverables/prompt-log.md` |
| 6 | Stage 2 feedback response | — | (incorporated via commit referencing PR feedback) |

## Final analysis structure

- **Company & Data Summary:** Present
- **Ratio Results & Interpretation:** Present — all six ratio categories covered with abundant numeric citations
- **Du Pont Analysis:** Present — four-factor decomposition with time-mismatch explanation
- **Strategic Recommendations:** Present — five data-backed recommendations with time horizons
- **LLM Evaluation & Annotations:** **Not present as a dedicated section** — see note below
- **Executive Justification:** Present — Managing Director framing with investment thesis

## Kindly-worded notes

**Strengths**

- Strategic recommendations are excellent — five well-reasoned, data-grounded recommendations with specific VND figures, time horizons, and implementation logic. Each rec connects at least two ratio categories.
- Executive voice section reads like an actual investment committee memo, with a clear thesis and risk-monitoring framework.
- Verification artifact covers five ratios across four categories with two genuine mismatches identified (Inventory Turnover denominator convention, DSO 360 vs 365 day convention).
- Du Pont decomposition is thorough with the 0.42pp time-mismatch gap quantified and explained.

**Areas for improvement**

- **LLM Evaluation & Annotations section missing from the final analysis.** The brief requires a dedicated section covering what the LLM executed correctly, where it deviated or hallucinated, and whether each issue traces to a spec gap or an LLM limitation. The verification artifact partially serves this purpose, but the rubric expects this as a standalone section within the final analysis document. Consider adding a section between "Strategic Recommendations" and "Executive Justification" walking through the LLM's performance.
- **Spec retrospective is thin.** The retrospective covers only about 20 lines with three spec sections evaluated. The template asks for: (1) section-by-section verdicts with evidence from the LLM output, (2) top three gaps with the specific symptom that surfaced each, (3) three concrete revisions, (4) a 1–5 effectiveness rating with anchored justification, and (5) a 150-word or shorter process feedback note on the template itself. Items 4 and 5 appear to be missing — adding them would strengthen this artifact.
- **Add a `LICENSE` file** at the repo root (MIT or Apache-2.0) — signals "this is a portfolio piece you may reference." Also set the one-line **repo description** on the GitHub repo page header — that's what shows up in LinkedIn link previews and search results.
- **Rename the spec file** from `.md.txt` to `.md`: `git mv docs/specs/2026-05-23-tran-vinamilk-spec.md.txt docs/specs/2026-05-23-tran-vinamilk-spec.md` — tooling indexes by the `.md` extension.
